kringle-pharmaCo., Ltd.

NEWS

notice

Aug 04, 2009 Notice

Kringle Pharma Finishes its Phase Ia Clinical Trial of Recombinant Human HGF for Treatment of Renal Disease.

Kringle Pharma Finishes its Phase Ia Clinical Trial of Recombinant Human HGF for Treatment of Renal Disease.